Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PZ Cormay

2006 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
CRM STOCK SYMBOL
2 INVESTMENTS
$0.21 SHARE PRICE (As of Wednesday Closing)
Description

PZ CORMAY SA is a manufacturer of diagnostic reagents and laboratory equipment. The company's products are used in Biochemistry, Hematology, Coagulation, Parasitology, Immunology, Urinalysis and Rapid tests.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Stock Exchange
WAR
Primary Office
  • 22 Wiosenna Street
  • Łomianki, 05-092
  • Poland

+48 22 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PZ Cormay’s full profile, request a free trial.

PZ Cormay Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.21 - $0.38 $17.9M $0.22 -$0.08 40.7K 84.2M

PZ Cormay Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 28,647 26,647 44,410 46,434
Revenue 18,462 19,314 20,536 20,843
EBITDA (4,592) (5,550) 778 (3,407)
Net Income (6,058) (6,913) (535) (2,784)
Total Assets 44,107 42,915 50,137 45,057
Total Debt 723 898 870 368
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PZ Cormay Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000 20-Jul-2011 000000000000000000 00.000 Diagnostic Equipment
Orphée 08-Oct-2009 Merger/Acquisition Other Devices and Supplies
To view this company’s complete investment and acquisition history, request access »

PZ Cormay Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000é0 08-Oct-2009 000000000000000000 Completed
  • 00 000000
To view this company’s complete exits history, request access »

PZ Cormay Subsidiaries (1)

Company Name Industry Location Founded
0000é0 Acquirer Geneva, Switzerland 0000
To view this company’s complete subsidiary history, request access »